Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
01/2003
01/09/2003CA2455654A1 Diagnosis and treatment of insulin-dependent diabetes mellitus and insulitis
01/09/2003CA2452039A1 Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease
01/09/2003CA2451840A1 Fused pyrimidine dhfr inhibitors as antibacterials
01/09/2003CA2451800A1 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
01/08/2003EP1272827A1 Analyte detection & apparatus therefor
01/08/2003EP1272493A2 A process for the preparation of decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]acenaphthylene and functionalized derivatives
01/08/2003EP1272492A2 Method for producing triethylene diamine, using ethylene diamine
01/08/2003EP1272185A2 Use of quinazoline derivatives as angiogenesis inhibitors
01/08/2003EP1087973B1 Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity
01/08/2003EP0915881B1 Pyrroloazepine compounds
01/08/2003EP0859768B1 Amine acid salt compounds and process for the production thereof
01/08/2003CN1390220A Kinase inhibitors as therapeutic agents
01/08/2003CN1390219A Pyrazolopyrimidines as therapeutic agents
01/08/2003CN1390217A Bicyclic and tricyclic heteroaromatic compounds
01/08/2003CN1390206A Inhibitors of factor Xa
01/08/2003CN1390201A Cyclic amine compounds as CCR5-antagonists
01/08/2003CN1389464A Blue modifier and its prepn. process and application
01/08/2003CN1389463A Condensed triheterocyclic compound
01/08/2003CN1098266C Fused pyrrolo (2,3-c) carbazole-6-one which potentiate activity of gamma interferon
01/08/2003CN1098264C Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases
01/07/2003US6504047 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
01/07/2003US6503949 Glucagon antagonists/inverse agonists
01/07/2003US6503908 Pharmaceutically active compounds
01/07/2003US6503900 [1,4]diazepino [6,7,1-jk ]carbazoles and derivatives
01/07/2003US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection
01/03/2003WO2003000696A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE
01/03/2003WO2003000695A1 Pyrrolopyrimidines as protein kinase inhibitors
01/03/2003WO2003000694A1 6-phenyldihydropyrrolopyrimidinedione derivatives
01/03/2003WO2003000693A1 Imidazotriazines for use as phosphodiesterase inhibitors
01/03/2003WO2003000692A2 Oxytocin agonists
01/03/2003WO2003000690A1 Synthesis of heterocyclic compounds employing microwave technology
01/03/2003WO2003000688A1 Azaindoles
01/03/2003WO2003000682A1 (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
01/03/2003WO2003000680A1 Diamine derivatives
01/03/2003WO2003000665A1 Antibacterial uracil derivatives
01/03/2003WO2003000657A1 Diamine derivatives
01/03/2003WO2003000269A2 Novel use for pde 10a inhibitors
01/03/2003WO2003000240A2 Stable powder inhalation dosage formulation
01/03/2003WO2003000187A2 Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
01/03/2003WO2002088101A3 Inhibitors of bace
01/03/2003WO2002072584A3 Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders
01/03/2003WO2002066020A3 Modulation of gsk-3beta activity and its different uses
01/03/2003WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
01/03/2003WO2002002563A3 Substituted-triazolopyrimidines as anticancer agents
01/03/2003WO2001044260A8 Novel purines
01/03/2003CA2451602A1 Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease
01/03/2003CA2451525A1 Imidazotriazines for use as phosphodiesterase inhibitors
01/03/2003CA2450555A1 (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
01/03/2003CA2450480A1 Oxytocin agonists
01/02/2003US20030004351 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
01/02/2003US20030004349 Vaporization, passed into a liquid solvent and crystallized
01/02/2003US20030004346 Synthesis of substituted pyrazolopyrimidines
01/02/2003US20030004334 Water-soluble porphyrin derivatives and methods of their preparation
01/02/2003US20030004172 Cardiovascular disorders, osteoporosis, multiple sclerosis, antiarthritic agents
01/02/2003US20030004168 Mixture of hypotensive agent and calcium channel blockers; cardiovascular disorders
01/02/2003US20030004167 Imidazo-heterobicycles as factor Xa inhibitors
01/02/2003US20030004164 Anticancer agents; autoimmune diseases
01/02/2003US20030004161 Anticancer agents; autoimmune diseases
01/02/2003US20030004159 Novel cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
01/02/2003US20030004153 Novel heteroaryl-diazabicycloalkanes
01/02/2003US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light
01/02/2003US20030000518 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
01/02/2003EP1271240A2 Silver halide color photographic material
01/02/2003EP1270578A1 Novel process for producing fused imidazopyridine derivative and novel crystal form
01/02/2003EP1270557A1 Ethylenediamine derivatives
01/02/2003EP1270008A2 Fused tricyclic analogues of guanosine for treating tumors
01/02/2003EP1268481A2 Kinase inhibitors as therapeutic agents
01/02/2003EP1268466A1 Decahydro-isoquinolines
01/02/2003EP1268449A1 Substituted piperidines as melanocortin receptor agonists
01/02/2003EP1268443A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
01/02/2003EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives
01/02/2003EP1268408A1 Arthropodicidal carboxanilides
01/02/2003EP1268368A2 Catalytic asymmetric desymmetrization of meso compounds
01/02/2003EP1268366A2 Modifying chemoselectivity during oxidation of nitrogen compounds
01/02/2003EP1267872A2 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
01/02/2003EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
01/02/2003EP1053246B1 Beta-sheet mimetics and methods relating to the use thereof
01/02/2003EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS
01/01/2003CN1388804A Amino acid-N-carboxy anhydrides having substitent at nitrogen
01/01/2003CN1388126A 吡咯并三嗪和嘧啶化合物 Pyrrolo-triazine and pyrimidine compounds
01/01/2003CN1388123A Chloropyrimidine intermediate
01/01/2003CN1097593C Process for preparation of hexanitrohexaazaiso-wurtzitanes
01/01/2003CN1097459C Diazepino-indoles as phosphodiesterase IV inhibitors
12/2002
12/31/2002US6500828 Triazolo-pyridazine derivatives as ligands for gaba receptors
12/31/2002US6500817 Thiazolyl urea derivatives and their utilization as antiviral agents
12/31/2002US6500816 Remedies for photochemotherapy
12/31/2002US6500472 For enriching foods or beverages, anemia treatment
12/27/2002WO2002104072A2 Emissive multichromophoric systems
12/27/2002WO2002102802A1 Novel pyrazolopyrimidinethione derivatives. preparation methods thereof and their use as therapeutics for erectile dysfunction
12/27/2002WO2002102793A2 Quinazolinediones as antibacterial agents
12/27/2002WO2002102792A1 Novel heterocyclic antibacterial compounds
12/27/2002WO2002102778A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
12/27/2002WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002WO2002088127A3 Triazolopyrimidines
12/27/2002WO2002083139B1 Inhibitors of akt activity
12/27/2002WO2002074753A3 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
12/27/2002WO2002070662A3 Three hybrid assay system
12/27/2002CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7